Abstract
Background
The association of obstructive sleep apnea (OSA) with nonalcoholic fatty liver disease (NAFLD) has only been studied in selected subgroups such as the morbidly obese. We aimed to determine the prevalence and effect of OSA on NAFLD and vice versa in unselected patients attending the outpatient department.
Methods
OSA was diagnosed by polysomnography, done in patients having symptoms of OSA, in patients with NAFLD attending the liver clinic. Polysomnography-proven patients with OSA attending the chest clinic were evaluated for NAFLD by ultrasonography. Anthropometry, liver function tests, metabolic syndrome evaluation and transient elastography were performed in all patients.
Results
Three (3 %; 95 % CI 1.03–8.45 %) out of 100 patients with NAFLD (mean age 41 ± 11 years) had symptomatic OSA. Of 23 patients with OSA (mean age 46 ± 12 years,), 3 (13 %) had mild, 5 (22 %) moderate and 15 (65 %) severe OSA. Twenty-one (91.3 %; 95 % CI 73.2–97.6 %) patients with OSA had NAFLD, while raised hepatic transaminase levels were seen in seven (30.4 %; 95 % CI 15.6–50.9 %). Body mass index (OR 1.21, 95 % CI 1.02–1.44) and male gender (OR 4.79, 95 % CI 1.12–20.48) were significant independent predictors of OSA in NAFLD. The apnea-hypopnea index (OR 1.084, 95 % CI 1.002–1.172), a marker of OSA severity, was the only significant independent predictor of significant fibrosis in patients with NAFLD.
Conclusions
Prevalence of symptomatic OSA in patients with NAFLD is low and is predicted by male gender and obesity. Prevalence of NAFLD in patients with OSA is very high. Significant hepatic fibrosis in patients with NAFLD is predicted by OSA independent of obesity and metabolic syndrome.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12072-015-9615-3/MediaObjects/12072_2015_9615_Fig1_HTML.gif)
Similar content being viewed by others
Abbreviations
- AASM:
-
American Academy of Sleep Medicine
- AHI:
-
Apnea-hypopnea index
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- AUROC:
-
Area under the receiver-operating curve
- BIA:
-
Bioelectrical impedance analyzer
- BMI:
-
Body mass index
- BP:
-
Blood pressure
- EDS:
-
Excessive daytime somnolence
- ESS:
-
Epworth sleepiness scale
- HDL:
-
High-density lipoprotein
- HIF:
-
Hypoxia-inducible factor
- HOMA-IR:
-
Homeostasis model assessment of insulin resistance
- LDL:
-
Low-density lipoprotein
- LSM:
-
Liver stiffness measurement
- NCEP-ATP:
-
National cholesterol education program-adult treatment panel
- NAFLD:
-
Nonalcoholic fatty liver disease
- NASH:
-
Nonalcoholic steatohepatitis
- NAS:
-
NAFLD activity score
- OSA:
-
Obstructive sleep apnea
- OSAS:
-
Obstructive sleep apnea syndrome
- Sat <90 %:
-
Percentage of total sleep time spent in hypoxia
References
Agrawal S, Duseja A. Non-alcoholic fatty liver disease: east versus west. J Clin Exp Hepatol 2012;2:122–134
Vecchierini MF. Obstructif sleep apnea–hypopnea syndrome: evolution of an old concept. Neurochirurgie 2006;52:432–442
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–1235
Reddy EV, Kadhiravan T, Mishra HK, Sreenivas V, Handa KK, Sinha S, et al. Prevalence and risk factors of obstructive sleep apnea among middle-aged urban Indians: a community-based study. Sleep Med 2009;10:913–918
Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham heart study. Hepatology 2010;51:1979–1987
Agrawal S, Sharma SK, Sreenivas V, Lakshmy R. Prevalence of metabolic syndrome in a north indian hospital-based population with obstructive sleep apnoea. Indian J Med Res 2011;134:639–644
Daltro C, Cotrim HP, Alves E, de Freitas LA, Araujo L, Boente L, et al. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence? Obes Surg 2010;20:1536–1543
Mishra P, Nugent C, Afendy A, Bai C, Bhatia P, Afendy M, et al. Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver Int 2008;28:1080–1086
Norman D, Bardwell WA, Arosemena F, Nelesen R, Mills PJ, Loredo JS, et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep 2008;31:121–126
Duseja A, Das A, Das R, Dhiman RK, Chawla Y, Bhansali A, et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the west. Dig Dis Sci 2007;52:2368–2374
Choo V. Who reassesses appropriate body-mass index for Asian populations. Lancet 2002;360:235
World Health Organisation, International Association for the study of obesity, international obesity task force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney, Health Communications Australia, 2000
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA 2001;285:2486–2497
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412–419
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, et al. Nash and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002;35:373–379
Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 1986;292:13–15
Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011;43:617–649
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–1321
Johns MW. A new method for measuring daytime sleepiness: the epworth sleepiness scale. Sleep 1991;14:540–545
Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;5:263–276
Duseja A, Das A, Dhiman RK, Chawla YK, Das R, Bhadada S, et al. Indian patients with nonalcoholic fatty liver disease presenting with raised transaminases are different at presentation. World J Gastroenterol 2007;13:649–650
Sanyal AJ. Aga technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705–1725
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231
Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004;39:770–778
Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2005;50:2338–2343
Rowley JA, Aboussouan LS, Badr MS. The use of clinical prediction formulas in the evaluation of obstructive sleep apnea. Sleep 2000;23:929–938
Kallwitz ER, Herdegen J, Madura J, Jakate S, Cotler SJ. Liver enzymes and histology in obese patients with obstructive sleep apnea. J Clin Gastroenterol 2007;41:918–921
Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54:1082–1090
Savransky V, Nanayakkara A, Vivero A, Li J, Bevans S, Smith PL, et al. Chronic intermittent hypoxia predisposes to liver injury. Hepatology 2007;45:1007–1013
Takayama F, Egashira T, Kawasaki H, Mankura M, Nakamoto K, Okada S, et al. A novel animal model of nonalcoholic steatohepatitis (NASH): hypoxemia enhances the development of NASH. J Clin Biochem Nutr 2009;45:335–340
Ye J. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) 2009;33:54–66
Chin K, Nakamura T, Takahashi K, Sumi K, Ogawa Y, Masuzaki H, et al. Effects of obstructive sleep apnea syndrome on serum aminotransferase levels in obese patients. Am J Med 2003;114:370–376
Aron-Wisnewsky J, Minville C, Tordjman J, Levy P, Bouillot JL, Basdevant A, et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2012;56:225–233
Culver C, Sundqvist A, Mudie S, Melvin A, **rodimas D, Rocha S. Mechanism of hypoxia-induced nf-kappab. Mol Cell Biol 2010;30:4901–4921
Li J, Fan R, Zhao S, Liu L, Guo S, Wu N, et al. Reactive oxygen species released from hypoxic hepatocytes regulates MMP-2 expression in hepatic stellate cells. Int J Mol Sci 2011;12:2434–2447
Moon JO, Welch TP, Gonzalez FJ, Copple BL. Reduced liver fibrosis in hypoxia-inducible factor-1 alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G582–G592
Compliance with Ethical Requirements
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study. Written informed consent was taken from all participants, and the study was approved by the institute’s ethics committee. This article does not contain any studies with animal subjects.
Conflict of interest
Swastik Agrawal, Ajay Duseja, Ashutosh Aggarwal, Ashim Das, Manu Mehta, Radha K Dhiman and Yogesh Chawla declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Agrawal, S., Duseja, A., Aggarwal, A. et al. Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center. Hepatol Int 9, 283–291 (2015). https://doi.org/10.1007/s12072-015-9615-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-015-9615-3